KETALAR (Page 4 of 4)
17 Patient Counseling Information
Studies conducted in young animals and children suggest repeated or prolonged use of general anesthetic or sedation drugs in children younger than 3 years may have negative effects on their developing brains. Discuss with parents and caregivers the benefits, risks, and timing and duration of surgery or procedures requiring anesthetic and sedation drugs [see Warnings and Precautions (5.5)].
Due to the residual anesthetic effects and the potential for drowsiness, advise patients not to drive an automobile, operate hazardous machinery, or engage in hazardous activities within 24 hours of receiving KETALAR.
Distributed by:
Par Pharmaceutical
Chestnut Ridge, NY 10977
8/2020
OS115J-01-90-053000442K
Sample Pacakge Label
KETALAR ketamine hydrochloride injection | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
|
Labeler — Henry Schein, Inc (012430880) |
Revised: 11/2023 Henry Schein, Inc
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.